NOS3 and colorectal carcinoma: On the other hand, the inhibition of endothelial nitric oxide synthase (eNOS) with L-NAME produced a slight rightward shift of the CRC of 5,8,4′-trihydroxy-3,7-dimethoxyflavone (18) (p = 0.99) (Figure 4).